3D bioprintable Mg<sup>2+</sup>-incorporated hydrogels tailored for regeneration of volumetric muscle loss.
Ontology highlight
ABSTRACT: Rationale: Current therapeutic approaches for volumetric muscle loss (VML) face challenges owing to limited graft availability and insufficient bioactivity. Three-dimensional (3D) bioprinting has become an alternative technology for fabricating native tissue-mimetic grafts, allowing for tailored structures and complex designs. Methods: We developed an Mg2+-incorporated bioink composed of thiolated gelatin (GtnSH) and maleimide-conjugated gelatin (GtnMI) decorated with magnesium peroxide (MgO2), referred to as a GtnSH/GtnMI/MgO2 bioink. We designed in situ crosslinking between GtnSH and GtnMI to prepare cytocompatible bioink for 3D bioprinting of muscle mimetics. Results: The incorporated MgO2 particles provided oxygen
SUBMITTER: Kang MS
PROVIDER: S-EPMC11840723 | biostudies-literature | 2025
REPOSITORIES: biostudies-literature
ACCESS DATA